AboutRomiplostim is a thrombopoietin (TPO) receptor agonist, functioning as a peptibody, a novel fusion protein. It consists of the Fc portion of a human immunoglobulin G1 (IgG1) linked to two identical single-chain peptides that specifically bind to and activate the human TPO receptor. This activation mimics the action of endogenous thrombopoietin, thereby stimulating megakaryopoiesis and significantly increasing platelet production in the bone marrow. By promoting the proliferation and differentiation of megakaryocytes, romiplostim effectively elevates platelet counts, reducing the risk of bleeding events in affected individuals. It is specifically indicated for the long-term treatment of chronic immune thrombocytopenia (ITP) in adult patients who have had an insufficient response to other treatments, such as corticosteroids, immunoglobulins, or splenectomy, offering a vital therapeutic option for managing this challenging condition.UsesChronic immune thrombocytopenia (ITP)Increase platelet countsReduce bleeding risk in ITPPatients refractory to other ITP treatmentsDirections For UseAdminister subcutaneously once weekly, as directed by a healthcare professional.
| Shipping Cost |
|
| Shop Location | Assam, India |
No comments found for this product. Be the first to comment!